Novel approaches to inflammation and infection in the cystic fibrosis lung.
Cantin
A M
AM
Dept of Medicine, University of Sherbrooke. a.cantin@courrier.usherb.ca
D003550:Cystic Fibrosis / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000502:physiology; D006801:Humans; D008168:Lung / Q000503:physiopathology; D011014:Pneumonia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator